Genomic analysis of anti-hepatitis B virus (HBV) activity by small interfering RNA and lamivudine in stable HBV-producing cells

Journal of Virology

Volumn 79, Issue 22, 2005, Pages 14392-14403

  Guo, Yong ^a,b,c   Guo, Hongyan ^a,b,c   Zhang, Liang ^c   Xie, Hongying ^c   Zhao, Xin ^c   Wang, Fangxun ^c   Li, Ze ^c   Wang, Yahui ^c   Ma, Shiliang ^d   Tao, Jiaping ^d   Wang, Weixing ^e   Zhou, Yuxiang ^a,b,c,f   Yang, Weiping ^c,f   Cheng, Jing ^a,b,f  

^a TSINGHUA UNIVERSITY   (China)

^b Tsinghua University   (China)

^c NATIONAL ENGINEERING RESEARCH CENTER FOR BEIJING BIOCHIP TECHNOLOGY   (China)

^d PEKING UNIVERSITY   (China)

^e PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^f CapitalBio Corporation   (China)

Author keywords

[No Author keywords available]

Indexed keywords

LAMIVUDINE; MESSENGER RNA; SMALL INTERFERING RNA; SMALL INTERFERING RNA 1; SMALL INTERFERING RNA 7; UNCLASSIFIED DRUG;

ACUTE HEPATITIS; ANTIVIRAL ACTIVITY; ARTICLE; CHRONIC HEPATITIS; CONTROLLED STUDY; DNA MICROARRAY; DRUG EFFICACY; DRUG MECHANISM; GENE ACTIVATION; GENE EXPRESSION PROFILING; GENE SEQUENCE; GENETIC CONSERVATION; GENOME ANALYSIS; HEPATITIS B VIRUS; HOST CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; LIVER CELL CARCINOMA; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; UNINDEXED SEQUENCE; VIRUS CELL INTERACTION; VIRUS GENE; VIRUS INHIBITION;

ANTIVIRAL AGENTS; BASE SEQUENCE; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CONSERVED SEQUENCE; GENETIC VECTORS; GENOME, VIRAL; HEPATITIS B VIRUS; HUMANS; LAMIVUDINE; LIVER NEOPLASMS; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS; RESTRICTION MAPPING; RNA, MESSENGER; RNA, SMALL INTERFERING; RNA, VIRAL; TRANSFECTION;

HEPATITIS B VIRUS;

EID: 27644507359     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.79.22.14392-14403.2005     Document Type: Article

References (49)

1. Andino, R. 2003. RNAi puts a lid on virus replication. Nat. Biotechnol. 21:629-630.
2. Brazma, A., P. Hingamp, J. Quackenbush, G. Sherlock, P. Spellman, C. Stoeckert, J. Aach, W. Ansorge, C. A. Ball, H. C. Causton, T. Gaasterland, P. Glenisson, F. C. Holstege, I. F. Kim, V. Markowitz, J. C. Matese, H. Parkinson, A. Robinson, U. Sarkans, S. Schulze-Kremer, J. Stewart, R. Taylor, J. Vilo, and M. Vingron. 2001. Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nat. Genet. 29:365-371.
3. Bridge, A. J., S. Pebernard, A. Ducraux, A. L. Nicoulaz, and R. Iggo. 2003. Induction of an interferon response by RNAi vectors in mammalian cells. Nat. Genet. 34:263-264.
4. Chen, Y., D. Du, J. Wu, C. P. Chan, Y. Tan, H. F. Kung, and M. L. He. 2003. Inhibition of hepatitis B virus replication by stably expressed shRNA. Biochem. Biophys. Res. Commun. 311:398-404.
5. de Veer, M. J., M. Holko, M. Frevel, E. Walker, S. Der, J. M. Paranjape, R. H. Silverman, and B. R. Williams. 2001. Functional classification of interferon-stimulated genes identified using microarrays. J. Leukoc. Biol. 69:912-920.
6. Dienstag, J. L., E. R. Schiff, T. L. Wright, R. P. Perrillo, H. W. Hann, Z. Goodman, L. Crowther, L. D. Condreay, M. Woessner, M. Rubin, and N. A. Brown. 1999. Lamivudine as initial treatment for chronic hepatitis B in the United States. N. Engl. J. Med. 341:1256-1263.
7. Dorsett, Y., and T. Tuschl. 2004. siRNAs: applications in functional genomics and potential as therapeutics. Nat. Rev. Drug Discov. 3:318-329.
8. Elbashir, S. M., J. Harborth, W. Lendeckel, A. Yalcin, K. Weber, and T. Tuschl. 2001. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411:494-498.
9. Ganem, D., and A. M. Prince. 2004. Hepatitis B virus infection-natural history and clinical consequences. N. Engl. J. Med. 350:1118-1129.
10. Giladi, H., M. Ketzinel-Gilad, L. Rivkin, Y. Felig, O. Nussbaum, and E. Galun. 2003. Small interfering RNA inhibits hepatitis B virus replication in mice. Mol. Ther. 8:769-776.
11. Guidotti, L. G., A. Morris, H. Mendez, R. Koch, R. H. Silverman, B. R. Williams, and F. V. Chisari. 2002. Interferon-regulated pathways that control hepatitis B virus replication in transgenic mice. J. Virol. 76:2617-2621.
12. Hamasaki, K., K. Nakao, K. Matsumoto, T. Ichikawa, H. Ishikawa, and K. Eguchi. 2003. Short interfering RNA-directed inhibition of hepatitis B virus replication. FEBS Lett. 543:51-54.
13. Hannon, G. J. 2002. RNA interference. Nature 418:244-251.
14. Jackson, A. L., S. R. Bartz, J. Schelter, S. V. Kobayashi, J. Burchard, M. Mao, B. Li, G. Cavet, and P. S. Linsley. 2003. Expression profiling reveals off-target gene regulation by RNAi. Nat. Biotechnol. 21:635-637.
15. Jonas, M. M., D. A. Kelley, J. Mizerski, I. B. Badia, J. A. Areias, K. B. Schwarz, N. R. Little, M. J. Greensmith, S. D. Gardner, M. S. Bell, and E. M. Sokal. 2002. Clinical trial of lamivudine in children with chronic hepatitis B. N. Engl. J. Med. 346:1706-1713.
16. Kamiya, N., A. Kubota, Y. Iwase, K. Sekiya, M. Ubasawa, and S. Yuasa. 2002. Antiviral activities of MCC-478, a novel and specific inhibitor of hepatitis B virus. Antimicrob. Agents Chemother. 46:2872-2877.
17. Klein, C., C. T. Bock, H. Wedemeyer, T. Wustefeld, S. Locarnini, H. P. Dienes, S. Kubicka, M. P. Manns, and C. Trautwein. 2003. Inhibition of hepatitis B virus replication in vivo by nucleoside analogues and siRNA. Gastroenterology 125:9-18.
18. Konishi, M., C. H. Wu, and G. Y. Wu. 2003. Inhibition of HBV replication by siRNA in a stable HBV-producing cell line. Hepatology 38:842-850.
19. Korba, B. E., and J. L. Gerin. 1992. Use of a standardized cell culture assay to assess activities of nucleoside analogs against hepatitis B virus replication. Antivir. Res. 19:55-70.
20. Korba, B. E., and G. Milman. 1991. A cell culture assay for compounds which inhibit hepatitis B virus replication. Antivir. Res. 15:217-228.
21. Lai, C. L., R. N. Chien, N. W. Leung, T. T. Chang, R. Guan, D. I. Tai, K. Y. Ng, P. C. Wu, J. C. Dent, J. Barber, S. L. Stephenson, D. F. Gray, and the Asia Hepatitis Lamivudine Study Group. 1998. A one-year trial of lamivudine for chronic hepatitis B. N. Engl. J. Med. 339:61-68.
22. Lau, D. T., M. F. Khokhar, E. Doo, M. G. Ghany, D. Herion, Y. Park, D. E. Kleiner, P. Schmid, L. D. Condreay, J. Gauthier, M. C. Kuhns, T. J. Liang, and J. H. Hoofnagle. 2000. Long-term therapy of chronic hepatitis B with lamivudine. Hepatology 32:828-834.
23. Lee, W. M. 1997. Hepatitis B virus infection. N. Engl. J. Med. 337:1733-1745.
24. McCaffrey, A. P., H. Nakai, K. Pandey, Z. Huang, F. H. Salazar, H. Xu, S. F. Wieland, P. L. Marion, and M. A. Kay. 2003. Inhibition of hepatitis B virus in mice by RNA interference. Nat. Biotechnol. 21:639-644.
25. Moore, M. D., M. J. McGarvey, R. A. Russell, B. R. Cullen, and M. O. McClure. 2005. Stable inhibition of hepatitis B virus proteins by small interfering RNA expressed from viral vectors. J. Gene Med. 7:918-925.
26. Morrissey, D. V., K. Blanchard, L. Shaw, K. Jensen, J. A. Lockridge, B. Dickinson, J. A. McSwiggen, C. Vargeese, K. Bowman, C. S. Shaffer, B. A. Polisky, and S. Zinnen. 2005. Activity of stabilized short interfering RNA in a mouse model of hepatitis B virus replication. Hepatology 41:1349-1356.
27. Morrissey, D. V., J. A. Lockridge, L. Shaw, K. Blanchard, K. Jensen, W. Breen, K. Hartsough, L. Machemer, S. Radka, V. Jadhav, N. Vaish, S. Zinnen, C. Vargeese, K. Bowman, C. S. Shaffer, L. B. Jeffs, A. Judge, I. Maclachlan, and B. Polisky. 2005. Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs. Nat. Biotechnol. 23:1002-1007.
28. Needleman, S. B., and C. D. Wunsch. 1970. A general method applicable to the search for similarities in the amino acid sequence of two proteins. J. Mol. Biol. 48:443-453.
29. Persengiev, S. P., X. Zhu, and M. R. Green. 2004. Nonspecific, concentration-dependent stimulation and repression of mammalian gene expression by small interfering RNAs (siRNAs). RNA 10:12-18.
30. Pfaffl, M. W. 1 May 2001, posting date. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29:e45.
31. Pugh, J. C., K. Yaginuma, K. Koike, and J. Summers. 1988. Duck hepatitis B virus (DHBV) particles produced by transient expression of DHBV DNA in a human hepatoma cell line are infectious in vitro. J. Virol. 62:3513-3516.
32. Ren, X. R., L. J. Zhou, G. B. Luo, B. Lin, and A. Xu. 2005. Inhibition of hepatitis B virus replication in 2.2.15 cells by expressed shRNA. J. Viral Hepatol. 12:236-242.
33. Robek, M. D., B. S. Boyd, S. F. Wieland, and F. V. Chisari. 2004. Signal transduction pathways that inhibit hepatitis B virus replication. Proc. Natl. Acad. Sci. USA 101:1743-1747.
34. Saxena, S., Z. O. Jonsson, and A. Dutta. 2003. Small RNAs with imperfect match to endogenous mRNA repress translation. Implications for off-target activity of small inhibitory RNA in mammalian cells. J. Biol. Chem. 278:44312-44319.
35. Seeger, C., and W. S. Mason. 2000. Hepatitis B virus biology. Microbiol. Mol. Biol. Rev. 64:51-68.
36. Sells, M. A., M. L. Chen, and G. Acs. 1987. Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA. Proc. Natl. Acad. Sci. USA 84:1005-1009.
37. Sells, M. A., A. Z. Zelent, M. Shvartsman, and G. Acs. 1988. Replicative intermediates of hepatitis B virus in HepG2 cells that produce infectious virions. J. Virol. 62:2836-2844.
38. Shlomai, A., and Y. Shaul. 2003. Inhibition of hepatitis B virus expression and replication by RNA interference. Hepatology 37:764-770.
39. Sledz, C. A., M. Holko, M. J. de Veer, R. H. Silverman, and B. R. Williams. 2003. Activation of the interferon system by short-interfering RNAs. Nat. Cell Biol. 5:834-839.
40. Stark, G. R., I. M. Kerr, B. R. Williams, R. H. Silverman, and R. D. Schreiber. 1998. How cells respond to interferons. Annu. Rev. Biochem. 67:227-264.
41. Sui, G., C. Soohoo, B. el Affar, F. Gay, Y. Shi, W. C. Forrester, and Y. Shi. 2002. A DNA vector-based RNAi technology to suppress gene expression in mammalian cells. Proc. Natl. Acad. Sci. USA 99:5515-5520.
42. Tang, N., A. L. Huang, B. Q. Zhang, G. Yan, and T. C. He. 2003. Potent and specific inhibition of hepatitis B virus antigen expression by RNA interference. Zhonghua Yixue Zazhi 83:1309-1312.
43. Uprichard, S. L., B. Boyd, A. Althage, and F. V. Chisari. 2005. Clearance of hepatitis B virus from the liver of transgenic mice by short hairpin RNAs. Proc. Natl. Acad. Sci. USA 102:773-778.
44. Van Gelder, R. N., M. E. von Zastrow, A. Yool, W. C. Dement, J. D. Barchas, and J. H. Eberwine. 1990. Amplified RNA synthesized from limited quantities of heterogeneous cDNA. Proc. Natl. Acad. Sci. USA 87:1663-1667.
45. Wu, H. L., L. R. Huang, C. C. Huang, H. L. Lai, C. J. Liu, Y. T. Huang, Y. W. Hsu, C. Y. Lu, D. S. Chen, and P. J. Chen. 2005. RNA interference-mediated control of hepatitis B virus and emergence of resistant mutant. Gastroenterology 128:708-716.
46. Wu, K. L., X. Zhang, J. Zhang, Y. Yang, Y. X. Mu, M. Liu, L. Lu, Y. Li, Y. Zhu, and J. Wu. 2005. Inhibition of hepatitis B virus gene expression by single and dual small interfering RNA treatment. Virus Res. 112:100-107.
47. Yang, Y. H., S. Dudoit, P. Luu, D. M. Lin, V. Peng, J. Ngai, and T. P. Speed. 15 February 2002, posting date. Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. Nucleic Acids Res. 30:e15.
48. Ying, C., E. De Clercq, and J. Neyts. 2003. Selective inhibition of hepatitis B virus replication by RNA interference. Biochem. Biophys. Res. Commun. 309:482-484.
49. Zhou, X. M., J. S. Lin, Y. Shi, D. A. Tian, H. J. Huang, H. J. Zhou, and Y. X. Jin. 2005. Establishment of a screening system for selection of siRNA target sites directed against hepatitis B virus surface gene. Acta Biochim. Biophys. Sin. 37:310-316.